There have been suggestions that guided biopsies on the basis of multiparametric MRI (mpMRI) data are most accurate when done using so-called “in-bore” or “in-gantry” biopsies as opposed to mpMRI/TRUS fusion-guided biopsies. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, lesion, MRI, multiparametric, target | 6 Comments »
It appears that the major pharma companies have initiated yet another merger frenzy, with at least two companies expressing interest in acquiring Medivation (the company that developed enzalutamide/Xtandi). … READ MORE …
Filed under: Uncategorized | Tagged: acquisition, Medivation, merger, target | Leave a comment »
A Shanghai-based research group has suggested that expression of MALAT-1 (metastasis-associated lung adenocarcinoma transcript 1), which is a large, non-coding ribonucleic acid (RNA), may be involved in some way with progression toward castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Drugs in development, Treatment | Tagged: castration-resistant, CRPC, MALAT-1, target | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 